{
    "2019-08-28": [
        [
            {
                "time": "",
                "original_text": "【广证恒生医药】-大参林（603233）-点评报告-“自建+并购”持续扩张，2019年H1利润同比增长32%，环比提速明显",
                "features": {
                    "keywords": [
                        "大参林",
                        "自建+并购",
                        "扩张",
                        "利润增长",
                        "环比提速"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国信医药|半年报点评】大参林：业绩超预期，现金流状况良好",
                "features": {
                    "keywords": [
                        "大参林",
                        "业绩超预期",
                        "现金流良好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "428家公司披露最新股东户数 306家筹码趋向集中",
                "features": {
                    "keywords": [
                        "股东户数",
                        "筹码集中"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【大参林】19年中报：Q2业绩继续提速超预期，强化内生提速和处方外流逻辑",
                "features": {
                    "keywords": [
                        "大参林",
                        "Q2业绩提速",
                        "内生增长",
                        "处方外流"
                    ],
                    "sentiment_score": 0.88,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大参林:持续深耕华南地区,业绩超预期",
                "features": {
                    "keywords": [
                        "大参林",
                        "深耕华南",
                        "业绩超预期"
                    ],
                    "sentiment_score": 0.87,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}